Lebenthal Global Advisors’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.92M Buy
5,242
+3,262
+165% +$1.31M 0.26% 71
2026
Q2
$823K Sell
1,980
-1,583
-44% -$587K 0.11% 134
2026
Q1
$964K Buy
3,563
+387
+12% +$115K 0.14% 116
2025
Q4
$1.05M Buy
3,176
+319
+11% +$108K 0.16% 96
2025
Q3
$987K Buy
+2,857
New +$864K 0.17% 89
2025
Q2
– Sell
-1,336
Closed -$700K – 205
2025
Q1
$700K Buy
+1,336
New +$683K 0.13% 103
2022
Q2
– Sell
-1,090
Closed -$555K – 150
2022
Q1
$555K Sell
1,090
-44
-4% -$21.2K 0.24% 75
2021
Q4
$569K Sell
1,134
-55
-5% -$24.9K 0.23% 62
2021
Q3
$464K Buy
1,189
+1
+0.1% +$414 0.29% 63
2021
Q2
$475K Buy
1,188
+24
+2% +$9.6K 0.26% 74
2021
Q1
$433K Sell
1,164
-26
-2% -$9.01K 0.27% 64
2020
Q4
$417K Buy
+1,190
New +$399K 0.3% 42

Other funds holding UNH

Lebenthal Global Advisors's UNH Position: Q3 2026 in Review

Lebenthal Global Advisors increased its UnitedHealth (UNH) stake by 165% in Q3 2026, buying an estimated $1.31M and bringing the position to 5,242 shares worth $1.92M. The position accounts for 0.26% of the portfolio, ranked #71.

Lebenthal Global Advisors first reported a position in UNH in Q4 2020 and has held it in 12 quarters since. 3,294 funds tracked by Wall St. Rank hold UNH as of Q3 2026.

  • Lebenthal Global Advisors held 5,242 shares of UnitedHealth worth $1.92M as of Q3 2026.
  • Lebenthal Global Advisors bought 3,262 UnitedHealth shares in Q3 2026, an estimated $1.31M.
  • UnitedHealth made up 0.26% of Lebenthal Global Advisors's portfolio in Q3 2026, its #71 holding.
  • Lebenthal Global Advisors first reported a position in UnitedHealth in Q4 2020 and has held it in 12 quarters since.
  • 3,294 funds tracked by Wall St. Rank held UnitedHealth as of Q3 2026.

Based on Lebenthal Global Advisors's 13F filing for Q3 2026, filed 28 Oct 2026.